phospho-CBL (Tyr774) Polyclonal Antibody, AbBy Fluor-647 Conjugated, BF647, Rabbit

Catalog Number: BSS-BS-3090R-BF647
Article Name: phospho-CBL (Tyr774) Polyclonal Antibody, AbBy Fluor-647 Conjugated, BF647, Rabbit
Biozol Catalog Number: BSS-BS-3090R-BF647
Supplier Catalog Number: bs-3090R-BF647
Alternative Catalog Number: BSS-BS-3090R-BF647-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: IF
Conjugation: BF647
Alternative Names: CBL2 Tyr774, CBL2 Y774, p-CBL2 Tyr774, p-CBL2 Y774, C CBL, Cas-Br-M murine ecotropic retroviral transforming sequence, Casitas B lineage lymphoma proto oncogene, CBL 2,E3 ubiquitin protein ligase CBL, Oncogene CBL2, Proto oncogene c CBL, RGD1561386, RING finger protein 55, RNF55v Signal transduction protein CBL, 4732447J05Rik, CBL_HUMAN.
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 867
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic phosphopeptide derived from human CBL2 around the phosphorylation site of Tyr774
Target: phospho-CBL (Tyr774)
Application Dilute: IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)